In our findings, the VEGF signaling pathway was one of the significantly enriched pathways suggesting that this pathway plays a biological function in the patients with EA with cardiovascular diseases and/or in CHD-related manifestations. This evidence concerns the gene VEGFA and cardiovascular disorder.